NCT05137691

Brief Summary

This trial is to assess the feasibility of a larger, definitive RCT and determine the clinical effectiveness of an NHS 1:1 programme versus a modified programme with a low carbohydrate dietary intervention (as per Feinman and colleagues classification) with telehealth, physical activity and enhanced behaviour change on specified health outcomes amongst post-partum women living with obesity

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
3

participants targeted

Target at below P25 for not_applicable obesity

Timeline
Completed

Started May 2022

Shorter than P25 for not_applicable obesity

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 18, 2021

Completed
1 month until next milestone

First Posted

Study publicly available on registry

November 30, 2021

Completed
6 months until next milestone

Study Start

First participant enrolled

May 19, 2022

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 15, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 15, 2022

Completed
Last Updated

October 21, 2022

Status Verified

October 1, 2022

Enrollment Period

4 months

First QC Date

October 18, 2021

Last Update Submit

October 19, 2022

Conditions

Keywords

weight management postpartum

Outcome Measures

Primary Outcomes (1)

  • Change in Bodyweight (Kilograms)

    Bodyweight measured by the CI or self-reported

    Proposed 0,3,6,8 months

Secondary Outcomes (10)

  • Change in Body composition (Fat mass/fat free mass)

    Proposed 0,3,6,8 months

  • Change in Waist circumference (Centimetres)

    Proposed 0,3,6,8 months

  • Change in systolic and diastolic Blood pressure

    Proposed 0,3,6,8 months

  • Change in Physical activity levels

    Proposed 0,3,6,8 months

  • Change in emotional eating using the Weight loss Readiness Test II

    0,3,6,8 months

  • +5 more secondary outcomes

Study Arms (2)

Experimental

EXPERIMENTAL

Adapted NHS weight management 1:1 programme. Low carbohydrate dietary focus, enhanced behaviour change via telehealth, daily step target supported by pedometers

Other: Adapted NHS weight management 1:1 programme

Active comparator NHS 1:1 weight management programme

ACTIVE COMPARATOR

12 week NHS 1:1 weight management programme

Other: NHS 1:1 weight management programme

Interventions

Adapted NHS 1:1 weight management programme with a low carbohydrate dietary focus, incorporating enhanced behaviour change via telehealth, step count and pedometer

Experimental

NHS 1:1 weight management programme

Active comparator NHS 1:1 weight management programme

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adult aged 18 or above
  • Ready and motivated to make lifestyle changes
  • Have a Body Mass Index of ≥30 kg/m2 (at initial booking appointment)
  • Additional study specific criteria
  • English speaking and ability to read English language
  • Capacity to consent to participating in the study
  • Are non-diabetic or those with Type 2 diabetes which is diet controlled
  • Deemed medically fit by GP/medical professional to participate via email
  • Have recently given birth (within 1 year)
  • Are not receiving weight management support elsewhere e.g. NHS, Scottish slimmers, weight watchers
  • Have access to a mobile phone and weighing scales

You may not qualify if:

  • Have uncontrolled hypothyroidism
  • Have unstable psychosis or severe and unstable personality disorder
  • Are pregnant
  • Have dementia
  • Have moderate to severe learning disability or learning difficulty which impairs the ability to adhere to the programme (identified by medical history and confirmed with GP)
  • Current alcohol or substance misuse (6 month period of abstinence)
  • Active purging
  • Bulimia Nervosa
  • Binge Eating Disorder
  • Additional study specific criteria
  • Known cancers
  • Type 1 Diabetes or Type 2 Diabetes on any Diabetic medication (including Insulin)
  • Have a pacemaker
  • Renal impairment
  • Taking Orlistat or any other weight loss medication or had previous bariatric surgery

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Astley Ainslie Hospital

Edinburgh, EH9 2HL, United Kingdom

Location

MeSH Terms

Conditions

Obesity

Condition Hierarchy (Ancestors)

OverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Ashleigh Graham

    Queen Margaret University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Model Details: Feasibility Randomised Controlled Trial
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Senior Practitioner in clinical research and Principal investigator

Study Record Dates

First Submitted

October 18, 2021

First Posted

November 30, 2021

Study Start

May 19, 2022

Primary Completion

September 15, 2022

Study Completion

September 15, 2022

Last Updated

October 21, 2022

Record last verified: 2022-10

Data Sharing

IPD Sharing
Will not share

Only anonymised data will be accessible by the rest of the current research team for purpose of statistical analysis and monitoring

Locations